COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,582 Articles (22,415 medRxiv, 8,167 bioRxiv)

Most recent first Previous |  Page 2308: Articles 23071-23080  | Next

In-depth Analysis of Laboratory Parameters Reveals the Interplay Between Sex, Age and Systemic Inflammation in Individuals with COVID-19
ten-Caten, F., Gonzalez-Dias, P., Castro, I., Ogava, R., Giddaluru, J., Silva, J. C., Martins, F., Goncalves, A. N., Costa-Martins, A. G., Araujo, J. D., Viegas, A. C., Cunha, F. Q., Farsky, S., Bozza, F. A., Levin, A. S., Pannaraj, P. S., de Silva, T. I., Minoprio, P., Andrade, B. B., da Silva, F. P., Nakaya, H. I.
10.1101/2020.08.07.20170043 — Posted: 2020-08-11
Markedly heterogeneous COVID-19 testing plans among US colleges and universities
Booeshaghi, A. S., Tan, F. H., Renton, B., Berger, Z., Pachter, L.
10.1101/2020.08.09.20171223 — Posted: 2020-08-11
Model to Describe Fast Shutoff of CoVID-19 Pandemic Spread
Eng, G.
10.1101/2020.08.07.20169904 — Posted: 2020-08-11
Quantifying threat from COVID-19 infection hazard in Primary Schools in England
Sparks, S. R., Aspinall, W. P., Cooke, R., Scarrow, J. H.
10.1101/2020.08.07.20170035 — Posted: 2020-08-11
Beneficial effects of colchicine for moderate to severe COVID-19: an interim analysis of a randomized, double-blinded, placebo controlled clinical trial
Lopes, M. I. F., Bonjorno, L. P., Giannini, M. C., Amaral, N. B., Benatti, M. N., Rezek, U. C., Emrich-Filho, L. L., Sousa, B. A., Almeida, S. C., Luppino-Assad, R., Veras, F. P., Schneider, A., Rodrigues, T. S., Leiria, L. O., Cunha, L. D., Alves-Filho, J. C., Cunha, T. M., Neto, E. A., Miranda, C. H., Pazin-Filho, A., Martins, M. A., Borges, M. C., Fonseca, B. A., Bollela, V. R., Cunha, F. Q., Zamboni, D. S., Santana, R. C., Vilar, F. C., Louzada-Junior, P., Oliveira, R. D. R.
10.1101/2020.08.06.20169573 — Posted: 2020-08-11 Discussion: Onsite
Whole Care Home Testing for Covid-19 in a Local Authority Area in the United Kingdom
Starling, A., White, E., Showell, D., Wyllie, D., Kapadia, S., Balakrishnan, R.
10.1101/2020.08.06.20162859 — Posted: 2020-08-11
Expanding COVID-19 symptom screening to retail, restaurants, and schools by preserving privacy using relaxed digital signatures
Jew, B., Korb, A., Lou, P., Chiang, J. N., An, U., Sahai, A., Halperin, E., Eskin, E.
10.1101/2020.08.06.20169839 — Posted: 2020-08-11
The impact of the COVID-19 pandemic on rabies reemergence in Latin America: the case of Arequipa, Peru
Raynor, B., Diaz, E. W., Shinnick, J., Zegarra, E., Monroy, Y., Mena, C., Castillo-Neyra, R.
10.1101/2020.08.06.20169581 — Posted: 2020-08-11 Discussion: Offsite
Indirect Impact of the COVID-19 Pandemic on Activity and Outcomes of Transcatheter and Surgical Treatment of Severe Aortic Stenosis in England
Martin, G. P., Curzen, N., Goodwin, A., Nolan, J., Balacumaraswami, L., Ludman, P., Kontopantelis, E., Wu, J., Gale, C. P., de Belder, M., Mamas, M. A.
10.1101/2020.08.05.20168922 — Posted: 2020-08-11
Time to negative PCR from symptom onset in COVID-19 patients on Hydroxychloroquine and Azithromycin - A real world experience
Saleemi, S. A., Alrajhi, A., Alhajji, M., Alfattani, A., Albaiz, F.
10.1101/2020.08.05.20151027 — Posted: 2020-08-11 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).